
Velaf 150mg Tablet ER
Marketer
Crescent Therapeutics Ltd
Salt Composition
Venlafaxine (150mg)
Overview Velaf 150mg Tablet ER
Avelox 150mg Extended-Release Tablets treat depression and anxiety. This medication modifies brain chemistry, addressing anxiety symptoms like agitation, hyperactivity, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take Avelox 150mg ER with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon remembering; never skip doses, and complete the prescribed course, even if feeling improved. Abrupt cessation is unsafe and may exacerbate symptoms. Common side effects may include queasiness, vomiting, sleep disturbances, reduced appetite, anxiety, bowel irregularity, excessive sweating, and sexual problems. Dizziness and drowsiness are possible; avoid driving or tasks needing concentration until the drug's effects are known. These side effects are usually transient. Persistent or bothersome side effects require medical attention. Before starting Avelox 150mg ER, disclose kidney, heart, or liver issues, or any seizure history (epilepsy). Report any unusual mood or behavioral changes, worsening depression, or suicidal thoughts to your physician.
Uses of Velaf 150mg Tablet ER
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Velaf 150mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Velaf 150mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Velaf 150mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Velaf 150mg Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Velaf 150mg Extended-Release tablet should be taken with a meal.
How Velaf 150mg Tablet ER works:
Velaf 150mg Extended-Release tablets function by elevating brain concentrations of serotonin and noradrenaline, neurotransmitters crucial for regulating mood and mental equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Combining Velaf 150mg Extended-Release Tablets with alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Velaf 150mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Velaf 150mg tablets are likely unsuitable for breastfeeding mothers. Preliminary human evidence indicates potential transfer to breast milk, posing a risk to the infant. Close observation of newborns for appropriate weight increase and alertness is recommended.
DrivingUNSAFE
Driving may be impaired by Velaf 150mg Extended-Release Tablets, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.
KidneyCAUTION
Extended-release Velaf 150mg tablets require careful administration for individuals with impaired renal function. Dosage modification of Velaf 150mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Velaf 150mg tablets require careful administration for individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Velaf 150mg Tablet ER :
For Velaf 150mg Extended-Release Tablets, take a missed dose promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Velaf 150mg Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Anisole-based compound |
| Developing Habits | No. |
| Type of Therapy | Neuroscience (CNS) |
| Actions | SNRIs (serotonin-norepinephrine reuptake inhibitors) |
